Cipher Pharmaceuticals Inc. (TSX: CPH)

Cipher Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 17, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	363	133	96	46	25	40
Market Cap Growth	262.53%	37.94%	107.72%	84.74%	-37.88%	-11.69%
Enterprise Value	406	77	59	27	23	49
Last Close Price	14.20	5.54	3.84	1.77	0.93	1.50
PE Ratio	16.62	4.94	2.68	4.73	4.34	9.62
Forward PE	15.80	11.11	8.77	3.95	4.53	5.00
PS Ratio	9.69	4.76	3.45	1.67	0.91	1.39
PB Ratio	2.72	1.25	1.11	0.94	0.60	1.11
P/TBV Ratio	-	1.60	1.56	1.88	1.55	16.19
P/FCF Ratio	-	6.31	6.70	2.66	1.69	4.37
P/OCF Ratio	22.07	6.30	6.65	2.66	1.69	3.93
EV/Sales Ratio	11.35	2.74	2.12	0.96	0.85	1.68
EV/EBITDA Ratio	23.71	5.07	3.67	1.54	1.39	3.00
EV/EBIT Ratio	30.38	5.63	3.97	1.61	1.51	3.28
EV/FCF Ratio	-4.48	3.63	4.12	1.53	1.58	5.28
Debt / Equity Ratio	0.41	0.00	0.01	0.01	0.06	0.34
Debt / EBITDA Ratio	3.22	0.03	0.04	0.04	0.14	0.75
Debt / FCF Ratio	-	0.02	0.04	0.04	0.16	1.34
Asset Turnover	0.22	0.26	0.33	0.46	0.48	0.44
Inventory Turnover	1.30	1.59	2.10	2.90	3.16	3.20
Quick Ratio	1.57	8.55	3.80	2.21	1.85	0.92
Current Ratio	2.00	9.19	4.07	2.39	2.03	1.04
Return on Equity (ROE)	17.98%	28.19%	51.73%	21.69%	14.46%	10.00%
Return on Assets (ROA)	5.05%	8.06%	11.01%	17.02%	16.76%	14.08%
Return on Capital (ROIC)	5.68%	8.86%	13.29%	22.09%	21.10%	17.95%
Earnings Yield	5.49%	20.23%	37.37%	21.14%	23.05%	10.39%
FCF Yield	-23.20%	15.86%	14.93%	37.64%	59.20%	22.87%
Buyback Yield / Dilution	2.82%	1.46%	3.84%	1.96%	-1.52%	0.15%
Total Shareholder Return	2.82%	1.46%	3.84%	1.96%	-1.52%	0.15%

Source: S&P Capital IQ. Standard template. Financial Sources.